Image Analysis Algorithms Integrated into Digital Pathology Solution

Leica Microsystems Tissue IA software is a key component of the total digital pathology portfolio and enables the analysis of whole slide images at the touch of a button.

The Indica Labs range, including algorithms for neurobiology, toxicological pathology, and brightfield in situ hybridization (ISH), can now be integrated with Leica's Tissue IA, providing a powerful, yet easy-to-use solution for a broad range of targeted applications. Users of the Leica Microsystems Tissue IA product can now source from Indica Labs, a range of image analysis algorithms, providing solutions to many diverse tissue-based quantification applications.

Furthermore, custom image analysis algorithms can be developed by Indica Labs to meet users’ varied and specific requirements, facilitating true flexibility in analysis options.

Donal O’Shea, head of digital pathology in Leica Microsystems said, “Leica Microsystems remains committed to our open and collaborative approach with third party vendors in the digital pathology market. This collaboration with Indica Labs provides additional choice for our digital pathology customers in translational research and biopharma, allowing them engage with a specialist vendor to seek high end image analysis capability, while leveraging the underlying power of Leica Microsystems Digital Pathology solution.”

Leica Microsystems will continue to develop and expand its existing range of Digital Pathology image analysis solutions, including Tissue IA and the Ariol system. The integration with Indica Labs gives additional options to customers, enabling them to choose the analysis solution that is right for their needs.

Related Links:
Indica Labs
Leica Microsystems